7539233

Source:http://linkedlifedata.com/resource/pubmed/id/7539233

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019134, umls-concept:C0087111, umls-concept:C0259507, umls-concept:C0282440, umls-concept:C0348016, umls-concept:C0443315, umls-concept:C1096777, umls-concept:C1861172
pubmed:issue	1
pubmed:dateCreated	1995-6-29
pubmed:abstractText	To compare the efficacy and safety of two subcutaneous doses of danaparoid with that of continuous intravenous administration of unfractionated heparin in the treatment of venous thromboembolism.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/7539233-8602716
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372351
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Chondroitin Sulfates, http://linkedlifedata.com/resource/pubmed/chemical/Dermatan Sulfate, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Heparin, http://linkedlifedata.com/resource/pubmed/chemical/Heparinoids, http://linkedlifedata.com/resource/pubmed/chemical/Heparitin Sulfate, http://linkedlifedata.com/resource/pubmed/chemical/danaproid
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0003-4819
pubmed:author	pubmed-author:BangaJ DJD, pubmed-author:BrouwerC BCB, pubmed-author:HartH CHC, pubmed-author:MeuwissenO JOJ, pubmed-author:NieuwenhuisH KHK, pubmed-author:SixmaJ JJJ, pubmed-author:WesterJ WJW, pubmed-author:de ValkH WHW, pubmed-author:van HessenM WMW
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	123
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1-9
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:7539233-Adult, pubmed-meshheading:7539233-Aged, pubmed-meshheading:7539233-Aged, 80 and over, pubmed-meshheading:7539233-Chondroitin Sulfates, pubmed-meshheading:7539233-Dermatan Sulfate, pubmed-meshheading:7539233-Drug Administration Schedule, pubmed-meshheading:7539233-Drug Combinations, pubmed-meshheading:7539233-Female, pubmed-meshheading:7539233-Hemorrhage, pubmed-meshheading:7539233-Heparin, pubmed-meshheading:7539233-Heparinoids, pubmed-meshheading:7539233-Heparitin Sulfate, pubmed-meshheading:7539233-Humans, pubmed-meshheading:7539233-Infusions, Intravenous, pubmed-meshheading:7539233-Injections, Subcutaneous, pubmed-meshheading:7539233-Male, pubmed-meshheading:7539233-Middle Aged, pubmed-meshheading:7539233-Pulmonary Embolism, pubmed-meshheading:7539233-Thromboembolism, pubmed-meshheading:7539233-Treatment Outcome
pubmed:year	1995
pubmed:articleTitle	Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial.
pubmed:affiliation	Department of Internal Medicine, Academic Hospital Utrecht, The Netherlands.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study